SUMMARY Twenty-one Parkinsonian patients were tested in on and off phases during chronic levodopa therapy for cognitive function, affective status, and evaluation of motor performance with reaction and movement times. A worsening of mood was observed from the on to the off phase. No variation in cognitive performance was observed from the on to the off phase in spite of evident motor changes. Mood changes during on-offvariations may reflect involvement of mesocortical and mesolimbic dopaminergic systems.
The relationship between cognitive and motor features of the disease, '3 14 has been the main point of these investigations, bearing with it the question of the functional role of the basal ganglia of humans in cognitive processes. '5 The dramatic evidence of fluctuations of motor symptoms during the on-off phases in Parkinson's disease patients has led some authors to study whether comparable cognitive variations accompany this treatment-induced phenomenon, '6 17 in the hope of shedding some light on the role that the multisystem dopaminergic disturbance of Parkinson's disease plays in the manifestations of cognitive impairment in that illness.
The present study investigated the changes in motor and cognitive functions and mood that occurred in Parkinson's disease patients presenting the on-off phenomenon. We chose verbal memory, verbal fluency, visuospatial orientation and attention,'8 since these functions have been reported to be affected in Parkinson's disease patients. Standardised measures of clinical status, motor reaction and movement times were also used to compare motor to cognitive performance in our patients.
Methods
Twenty-one non-demented patients (14 males and seven females) with idiopathic Parkinson's disease and 21 controls (13 males and eight females) were examined. The mean age of the patients was 58 + 8 1 years and mean duration of illness II + 4-8 years, the mean age of the controls was 57-8 + 7 years.
All the patients were undergoing treatment with levodopa plus peripheral decarboxylase inhibitor. In some, bromocriptine (nine patients) or lisuride (five patients) were also given. All patients were affected by a severe form of the disease and experienced on-off fluctuations. Girotti, Carella, Grassi, Soliveri, Marano, Caraceni Some tests in the present study did significantly discriminate between patients and controls but no test changed between the on and the off phase in spite of the dramatic motor changes. These results, showing that there was no cognitive variation from the on to the off phase, are in agreement with those of Brown et al, 17 who attributed the minor cognitive changes they observed from the on to the off phase to the more relevant changes in affect/arousal and did not confirm the variation in verbal fluency and memory of the single care report of Delis et al."6 In accordance with Brown et al'7 is our observation of a worsening of affective status in the off phase. It is noteworthy that the changes in the psychiatric rating total score could be accounted for almost entirely by the changes in depressive mood and anxiety scores. Although an obvious reactive change may occur in the passage from a state of relative well-being to one of almost helpless immobility, the observation of intense and paroxysmal change in mood in three patients of our series all of them showing prominent diphasic dyskinesia, may suggest a true dopaminergic dysfunction of mesolimbic systems30 31 and not a reactive affective change. Such intense mood swings were also 
